KUALA LUMPUR, Jan 4 ― The National Pharmaceutical Regulatory Agency (NPRA) is investigating a report from the Kajang Prison on the adverse events following Covid-19 immunisation (AEFI) cases involving 18 inmates, the agency's director said today. The investigation comes after a letter from the.